Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Sanford Applied Biosciences Supporting VEE Countermeasure Research

by Global Biodefense Staff
March 24, 2014

Sanford Applied Biosciences (SAB) is being awarded a sole-source contract to provide research and development services in support of a feasibility study for use of Transchromosomic Bovine derived polyvalent human immunoglobin (Tc pAb) as a therapeutic or prophylactic agent against Venezuelan equine encephalitis (VEE).

Naval Medical Research Center (NMRC) is leading the research effort. This acquisition pertains to a particular segment of the study wherein SAB research staff has the unique capability and expertise in performing the required tasks involving the preparation and execution of Transchromosomic Bovine (Tc BovineTM) vaccination and post-vaccination serum sampling.

The base period of performance will be for 24 months and has an estimated value of $933,042.00 and there will be a 24 month option period with an estimated value of $759,960.00. The total estimated value of the contract including all options is $1,692,138.00.

SAB has developed the world’s first large animal platform technology to produce fully human antibodies, both monoclonal and polyclonal, using the latest advances in gene engineering and transfer to produce new biopharmaceuticals that help fight disease. The antibodies generated in this unique system have been shown to have high diversity and high affinity compared to other genetically engineered animal systems.

The company, headquartered in Sioux Falls, South Dakota is a part of Sanford Health, the largest rural health organization in the United States.

Source: FBO.gov

Tags: Awards

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC